| CONTACTS: |
César García, Chairman and Chief Executive Officer |
|
818-709-1244
|
|
-or-
|
|
Ron Stabiner, The Wall Street Group, Inc. |
|
212-888-4848 |
CHATSWORTH, CA, July 14, 2008 - IRIS INTERNATIONAL, INC. (NASDAQ: IRIS),
a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that it will host a financial
analyst reception and presentation on Tuesday, July 29, 2008, at the Annual Association of Clinical Chemistry (AACC) 2008 Annual Meeting and Exposition in Washington, DC.
Beginning at 4:00 p.m., Eastern time, IRIS senior management, led by César García, Chairman and CEO, will provide an overview and product
demonstration at the Company's booth no. 2427 at the Washington Convention Center, 801 Mount Vernon Place, Washington, DC, to be followed by a cocktail reception and presentation
from 5:00 – 7:00 p.m. at the Company's suite in the Madison Hotel, 1177 15th St., NW, Wash., DC. Shuttle service from the Convention Center to the hotel will be provided.
Attendance is by invitation only and limited to financial analysts and institutions. Those interested in attending are asked to contact Ron Stabiner at
The Wall Street Group, Inc., 212-888-4848, or
ABOUT IRIS INTERNATIONAL
IRIS International is a leading global in vitro diagnostics company focused on products that analyze particles and living cell forms and structures, or morphology of a variety of body
fluids. Our products leverage our strengths in flow imaging technology, particle recognition and automation to bring efficiency to hospital and commercial laboratories. The initial
applications for our technology have been in the urinalysis market and we are the leading worldwide provider of urine microscopy systems, with an installed based of more than 1,800
systems in over 50 countries.